Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials

<table>Relative risk of total fractures, vertebral fractures, and nonvertebral fractures for postmenopausal women between the alendronate group and the raloxifene group. NV: nonvertebral.</table>

International Journal of Endocrinology

fig2

Figure 2

Figure 2: Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials 